Navigation Links
Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
Date:5/20/2013

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Today at American Society for Microbiology conference, award lecturer Dr. Christine Ginocchio discussed Specific Technologies blood culture system as an upcoming solution for rapid identification of microorganisms producing bloodstream infection. Dr. Ginocchio is the Senior Medical Director and Chief of the Division of Infectious Disease Diagnostics at North Shore-LIJ Health System, the nation's 2nd largest not-for-profit, non-sectarian health system.

(Photo: http://photos.prnewswire.com/prnh/20130520/CG16829)

At the BD Award for Research in Clinical Microbiology presentation "Rapid Detection and Identification of Blood Stream Pathogens" Dr. Ginocchio described the groundbreaking Specific Technologies solution that identifies microorganisms during culture. Current standard practice requires completion of a blood culture and then requires additional time consuming and expensive molecular or chemical analysis. The Specific Technologies solution has demonstrated detection of infection and identification of species in blood culture 4-fold faster than the industry standard technology leading to early intervention that can save lives, with less lab labor and no additional instruments. 

Bloodstream infection causing sepsis is the 10th leading cause of death, responsible for 11% of ICU admissions, with a mortality rate estimated at 28% to 50%, adding up to $50K costs per patient. To determine blood infection worldwide more than 150 million blood cultures are performed annually. Time is of the essence, survival rates decrease every hour without effective antibiotic treatment.  Current blood culture practice typically takes 2 to 3 days before results can guide the effective antibiotic choice.

Dr. Ginocchio remarked, "During growth in culture bacteria produce small molecule volatile metabolites unique to their species and strain. The Specific Technologies system for identifying the microorganism from its metabolomic signature is an exciting new technology that can save precious hours critical to effective treatment of bloodstream infection causing sepsis."

Ray Martino a founder and COO of Specific Technologies, commented, "Current blood culture systems can only indicate the presence or absence of bacteria, with no information regarding ID. Not only does the Specific Tech system provide ID during culture but analytical studies have shown ID is provided more than 20% faster than current systems simply detect a positive presence."

Mr. Martino continued "We appreciate the consideration of Dr. Ginocchio a widely recognized expert in microbiology and infectious disease attested to by her track record of research and clinical leadership and advisory positions to the FDA, NIH, and IDSA, her grants, and her invited talks."

About Specific Technologies

Specific Technologies has developed in vitro diagnostic systems for rapid identification of microorganisms to diagnose infections that lead to serious medical conditions including sepsis. The company's unique, patented, metabolomic signature technology identifies microorganisms during culture growth before existing technologies based on molecular or chemical tests can be deployed resulting in faster diagnosis with less labor and no additional instruments. Specific Technologies is located in Mountain View, CA.

For additional information on the Company, please visit www.specifictechnologies.net .

Media Contact: Anders Berliner , Specific Technologies, 561-659-5400, aberliner@specifictechnologies.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Specific Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
2. Argos Confirms Improved RNA Amplification Protocol Enhances Quality of Antigen-Specific Immune Response
3. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
4. ImmusanTs Epitope-Specific Immunotherapy for Celiac Disease Informs the Potential of Vaccines Against Other Autoimmune Diseases
5. Both Biosimilar and Reference Biologics Companies Must consider Various Product-Specific and Regional Strategies to Navigate a Dynamic and Uncertain Global Market
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
7. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, March 12, 2013
9. GPMG Product Helps Medical Device Specification Developers be FDA and ISO 13485 Compliant
10. BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences
11. While Half of Facial Injectable Patients Request A Specific Product, Most Still Remain Unaware of Many Brands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Biosimilar Clinical Trial & Opportunity Insight" report by PNS Pharma gives comprehensive ... Currently 5 biosimilar version of Lantus are commercially available in ... , Czech Republic , Estonia , ... Slovakia , United Kingdom for the treatment ... in 2014. Lantus is the brand name for Insulin Glargine, a ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... -- A new investigational drug originally developed for type 2 ... of the world,s first treatment to impede the progression of ... in the journal Science Translational Medicine . ... for millions of people living with Parkinson,s disease," says ... Research Institute,s Center for Neurodegenerative Science , chairman ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood ... study appearing online in the journal Radiology. , Heart disease and brain disease exact ... to the rapidly aging population. Damage to both organs often occurs at a subclinical ...
(Date:12/7/2016)... ... December 07, 2016 , ... ODU, ... to the US market its advanced highly customizable contact technology solutions. , ODU ... These advanced technologies are ideal for a wide range of applications that require ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... planning services to families and business owners in the greater Dallas metropolitan area, ... the Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals ...
(Date:12/7/2016)... ... 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering insurance ... launching a charity drive to raise funds that will benefit the Marine Corps League. ... and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team ...
(Date:12/7/2016)... Honolulu, HI (PRWEB) , ... December 07, 2016 ... ... Dermatology is proud to announce that its fully redesigned website, which launched October ... well as a sleek responsive design and easy-to-navigate layout. Visitors and patients can ...
Breaking Medicine News(10 mins):